Callisto Pharmaceuticals, Inc. · New York, NY United States (OTC: CLSP)
| 420 Lexington Ave., Ste. 1609 | Phone: 212-297-0010 |
| New York, NY | Fax: 212-297-0020 |
| 10170 | |
| United States | 
Map This Company |
Callisto Pharmaceuticals, Inc. Rankings
Company Description
Callisto Pharmaceuticals is working on a constellation of medical therapies. Its drug candidates include treatments for gastrointestinal diseases, inflammatory conditions, and a variety of cancers. The company is developing certain candidates through licensing and development agreements with other drug and research organizations, such as
To read the full description: Subscribe Now
Callisto Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: CLSP Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 10 |
Executives
7 executives listed for Callisto Pharmaceuticals, Inc.'s New York, NY location.
| Chairman, Callisto Pharmaceuticals and Pawfect | Gabriele Cerrone | |
|---|---|---|
| CEO and Director; President and Acting CEO, Pawfect | Gary Jacob | |
| SVP Finance and Secretary, Callisto Pharmaceuticals and Pawfect | Bernard Denoyer |